TC Biopharm (Holdings) (TCBPW) Stock Analysis
NASDAQHealthcareBiotechnology
What TC Biopharm (Holdings) does
TC Biopharm (Holdings) Plc is a biopharmaceutical firm currently in the clinical trial phase, dedicated to advancing immunotherapy treatments. Their core approach revolves around an innovative allogeneic gamma delta T cell platform. The company's development portfolio features OmnImmune, an unmodified cell therapy designed to treat acute myeloid leukemia, and ImmuniStim, another unmodified cell therapy undergoing development for COVID-19. Additionally, they are working on TCB009, which targets gastrointestinal tract cancers. Further along, TCB005 and TCB006 are preclinical-stage allogeneic co-stimulatory GD-T CAR candidates intended to address various types of solid tumors. This company was established in 2013 and operates from its headquarters in Motherwell, United Kingdom.
Key metrics
ETFs linked to TCBPW
Broad-market and Healthcare sector ETFs an investor holding TC Biopharm (Holdings) is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how TCBPW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze TCBPW in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for TC Biopharm (Holdings)?
- TC Biopharm (Holdings) trades under the ticker TCBPW on NASDAQ.
- Which exchange is TCBPW listed on?
- TCBPW is listed on NASDAQ.
- What sector does TC Biopharm (Holdings) operate in?
- TC Biopharm (Holdings) is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze TCBPW in a portfolio?
- PortView shows TCBPW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.